Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Tokyo - Delayed Quote JPY

Nakanishi Inc. (7716.T)

Compare
1,993.00
-79.00
(-3.81%)
At close: April 4 at 3:30:00 PM GMT+9
Loading Chart for 7716.T
  • Previous Close 2,072.00
  • Open 2,044.00
  • Bid 1,990.00 x --
  • Ask 2,000.00 x --
  • Day's Range 1,966.00 - 2,063.00
  • 52 Week Range 1,966.00 - 2,758.00
  • Volume 205,400
  • Avg. Volume 262,498
  • Market Cap (intraday) 167.651B
  • Beta (5Y Monthly) 0.18
  • PE Ratio (TTM) 19.72
  • EPS (TTM) 101.05
  • Earnings Date May 12, 2025
  • Forward Dividend & Yield 56.00 (2.81%)
  • Ex-Dividend Date Jun 27, 2025
  • 1y Target Est 2,983.33

Nakanishi Inc. manufactures and sells dental and surgical products in Japan and internationally. The company offers air turbines; clinical micromotors; contra-angles; and mobile dentistry, oral hygiene, endodontic, surgical, dental laboratory, and hygiene and maintenance products. It also provides general industrial cutting and grinding equipment. Nakanishi Inc. was founded in 1930 and is headquartered in Kanuma, Japan.

www.japan.nsk-dental.com

2,180

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 7716.T

View More

Performance Overview: 7716.T

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

7716.T
16.75%
Nikkei 225 (^N225)
15.33%

1-Year Return

7716.T
10.53%
Nikkei 225 (^N225)
15.07%

3-Year Return

7716.T
6.35%
Nikkei 225 (^N225)
21.79%

5-Year Return

7716.T
61.49%
Nikkei 225 (^N225)
89.56%

Compare To: 7716.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 7716.T

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    167.65B

  • Enterprise Value

    139.27B

  • Trailing P/E

    19.72

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.20

  • Price/Book (mrq)

    1.38

  • Enterprise Value/Revenue

    1.81

  • Enterprise Value/EBITDA

    7.11

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.13%

  • Return on Assets (ttm)

    6.10%

  • Return on Equity (ttm)

    7.32%

  • Revenue (ttm)

    77.04B

  • Net Income Avi to Common (ttm)

    8.58B

  • Diluted EPS (ttm)

    101.05

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    47.11B

  • Total Debt/Equity (mrq)

    15.45%

  • Levered Free Cash Flow (ttm)

    9.57B

Research Analysis: 7716.T

View More

Company Insights: 7716.T

Research Reports: 7716.T

View More

People Also Watch